What is the recommended management for primary hyperparathyroidism?

Management of Primary Hyperparathyroidism

Parathyroidectomy is the only definitive cure for primary hyperparathyroidism and should be recommended for all symptomatic patients and most asymptomatic patients who meet surgical criteria, as it is more cost-effective than observation or pharmacologic therapy and improves bone mineral density, quality of life, and long-term survival. 1, 2

Initial Diagnostic Workup

Before determining management strategy, complete the following evaluation:

• Measure serum intact parathyroid hormone (PTH) when serum calcium is high or high-normal to confirm the diagnosis 3
• Obtain 25-hydroxyvitamin D levels and correct deficiency to ≥50 nmol/L (20 ng/mL), with a goal of ≥75 nmol/L (30 ng/mL) being reasonable 1, 4
• Perform 24-hour urine calcium measurement to assess calcium excretion 1
• Obtain dual-energy x-ray absorptiometry (DEXA) to evaluate bone mineral density 1
• Review imaging studies to quantify stone burden and assess for nephrocalcinosis, as multiple or bilateral renal calculi suggest higher recurrence risk 3

Surgical Management (First-Line Treatment)

Indications for Surgery

Surgery is indicated for:

• All symptomatic patients (bone demineralization, fractures, nephrolithiasis, muscle weakness, neurocognitive symptoms) 3, 1
• Asymptomatic patients meeting guideline criteria 1, 2

Preoperative Imaging

Obtain cervical ultrasonography or other high-resolution imaging for operative planning 1. The highest imaging accuracy is achieved with 4DCT and PET scans, particularly when multiglandular disease is suspected 5. Patients with nonlocalizing imaging remain surgical candidates and should not be denied surgery 1.

Avoid preoperative parathyroid biopsy 1.

Surgical Approach Selection

Two curative operative strategies exist:

Focused, image-guided surgery (minimally invasive parathyroidectomy - MIP):

• Appropriate for single-gland disease (80% of cases) 3, 1
• Requires intraoperative PTH monitoring via a reliable protocol 1
• Success defined as ≥50% PTH drop and/or levels below 40 pg/mL 5
• Not routinely recommended for known or suspected multigland disease 1

Bilateral neck exploration (BNE):

• Essential for multiglandular disease (15-20% of cases) 3, 2
• Required when imaging is discordant or nonlocalizing 3
• Necessary when high suspicion for multiple adenomas or hyperplasia exists 3, 1

Both approaches achieve cure rates exceeding 97% in experienced hands 2. Surgeons who perform high-volume operations have superior outcomes 1.

Intraoperative Considerations

• Routinely consider the possibility of multigland disease during surgery 1
• Use ex vivo aspiration of resected parathyroid tissue to confirm parathyroid tissue intraoperatively 1
• Assess and manage clinically relevant thyroid disease during parathyroidectomy 1
• Autotransplant devascularized normal parathyroid tissue 1

Postoperative Management

Immediate postoperative period (first 48-72 hours):

• Measure ionized calcium every 4-6 hours for 48-72 hours, then twice daily until stable 3
• Observe for hematoma formation 1
• Evaluate for hypocalcemia and symptoms (perioral numbness, muscle cramps, tetany) 1

If ionized calcium falls below 0.9 mmol/L (corrected total calcium <7.2 mg/dL):

• Initiate calcium gluconate infusion at 1-2 mg elemental calcium/kg/hour 3
• Gradually reduce infusion when ionized calcium normalizes and remains stable 3
• When oral intake is possible, provide calcium carbonate 1-2 g three times daily plus calcitriol up to 2 μg/day 3

Long-term follow-up:

• Assess for cure defined as eucalcemia at >6 months postoperatively 1
• Calcium supplementation may be indicated postoperatively based on serum levels 1

Medical Management (Non-Surgical Alternative)

Medical therapy is NOT an alternative to surgery but should be reserved for patients who meet surgical criteria but are unable or unwilling to undergo parathyroidectomy, or have failed surgery 6, 4, 7.

General Measures

• Recommend adequate hydration in all patients 7
• Do NOT restrict calcium intake—follow established guidelines for general population 4, 7
• Correct vitamin D deficiency to achieve 25-hydroxyvitamin D ≥50 nmol/L (20 ng/mL), with ≥75 nmol/L (30 ng/mL) being a reasonable goal 4, 7

Pharmacologic Options

For lowering serum calcium:

• Cinacalcet is the treatment of choice 4
• Reduces serum calcium to normal in many cases 4
• Has only modest effect on PTH levels 4
• Does NOT improve bone mineral density 4

For improving bone mineral density:

• Bisphosphonate therapy (alendronate has best evidence) 4
• Improves BMD at lumbar spine 4
• Does NOT alter serum calcium concentration 4

For both lowering calcium AND improving BMD:

• Combination therapy with cinacalcet plus bisphosphonate is reasonable, though strong evidence for efficacy is lacking 4

Special Populations

Pregnant women:

• Treat conservatively with hydration 7
• If surgery needed, perform in second trimester 7

Severe hypercalcemia:

• Life-threatening condition requiring immediate intensive treatment 7

Common Pitfalls to Avoid

• Do not deny surgery to patients with nonlocalizing imaging—they remain surgical candidates 1
• Do not perform preoperative parathyroid biopsy 1
• Do not use minimally invasive parathyroidectomy for known/suspected multigland disease 1
• Do not restrict calcium intake in patients not undergoing surgery 4, 7
• Do not use medical therapy as a substitute for surgery in surgical candidates—it is only for those unable or unwilling to have surgery 6, 4, 7